HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hayes M Dansky Selected Research

Withholding Treatment

1/2014Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.
10/2011Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hayes M Dansky Research Topics

Disease

8Atherosclerosis
05/2009 - 02/2002
4Coronary Disease (Coronary Heart Disease)
11/2014 - 10/2009
2Hyperglycemia
11/2007 - 08/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2014
1Peripheral Arterial Disease
01/2012
1Atherosclerotic Plaque (Atheroma)
01/2012
1Hypercholesterolemia
10/2011
1Hyperlipidemias (Hyperlipidemia)
10/2011
1Infection
10/2008
1Vascular Diseases (Vascular Disease)
11/2007
1Obesity
10/2006
1Insulin Resistance
10/2006
1Hyperplasia
07/2006
1Abdominal Aortic Aneurysm
04/2005
1Inflammation
10/2004

Drug/Important Bio-Agent (IBA)

5anacetrapibIBA
11/2014 - 10/2009
5Apolipoproteins E (ApoE)IBA
05/2009 - 04/2002
4Cholesterol Ester Transfer ProteinsIBA
11/2014 - 10/2011
4Lipoproteins (Lipoprotein)IBA
01/2014 - 04/2002
4ApolipoproteinsIBA
05/2009 - 01/2003
4CholesterolIBA
11/2006 - 04/2002
3Insulin (Novolin)FDA Link
11/2007 - 08/2006
2LDL CholesterolIBA
11/2014 - 01/2014
2HDL CholesterolIBA
11/2014 - 01/2014
2LipidsIBA
01/2014 - 08/2006
2LDL Receptors (LDL Receptor)IBA
05/2009 - 10/2006
1Biological Markers (Surrogate Marker)IBA
01/2012
1atorvastatin (Lipitor)FDA Link
10/2011
1Cell Adhesion MoleculesIBA
10/2008
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
10/2008
1CytokinesIBA
10/2008
1ChemokinesIBA
10/2008
1NF-kappa B (NF-kB)IBA
10/2008
1Aldehyde Reductase (Aldose Reductase)IBA
10/2006
1Dietary Fats (Ghee)IBA
10/2006
1AngiotensinsIBA
04/2005
1Angiotensin IIIBA
04/2005
1CollagenIBA
10/2004
1HDL LipoproteinsIBA
10/2004
1RNA (Ribonucleic Acid)IBA
02/2002

Therapy/Procedure

2Withholding Treatment
01/2014 - 10/2011
1Transplants (Transplant)
07/2006
1Therapeutics
04/2002